Treatment of HIV‐infected patients with highly active antiretroviral therapy (HAART) usually
results in diminished viral replication, increasing CD4+ cell counts, a reversal of most …

Lipodystrophy is a group of clinically heterogeneous, inherited or acquired, disorders
characterized by complete or partial absence of subcutaneous adipose tissue that may …

C lass B GPCRs of the secretin family are important drug targets in many human diseases
including diabetes, neurodegeneration, cardiovascular disease and psychiatric disorders. X …

Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart
failure (HF) in older adults. The primary chronic symptom in patients with HFpEF, even when …

More than 2 million children globally are living with HIV infection and> 90% of these reside
in sub-Saharan Africa. Severe acute malnutrition (SAM) remains a major problem for HIV …

Introduction Growth hormone (GH) increases lean body mass, decreases fat mass,
increases exercise tolerance and maximum oxygen uptake, enhances muscle strength, and …

HIV-associated lipodystrophy syndrome (HALS), comprising metabolic and morphological
alterations, is a known side effect of highly active antiretroviral therapy (HAART). Evidence …

Growth hormone secretagogues (GHSs) are a generic term to describe compounds that
increase growth hormone (GH) release. GHSs include agonists of the growth hormone …

Treatment with highly active antiretroviral drugs (HAART) is associated with several
endocrine and metabolic comorbidities. Pituitary growth hormone (GH) secretion seems to …

The metabolic syndrome (MetS), a cluster of risk factors for cardiovascular disease and type
2 diabetes, has become an important public health problem. Considerable differences in the …